Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis
Crossref DOI link: https://doi.org/10.1245/s10434-021-10048-4
Published Online: 2021-05-03
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sugarbaker, Paul H.
Chang, David
Text and Data Mining valid from 2021-05-03
Version of Record valid from 2021-05-03
Article History
Received: 4 January 2021
Accepted: 1 April 2021
First Online: 3 May 2021
Diclosures
: Paul H. Sugarbaker and David Chang have no disclosures to declare.